BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent infection. METHODS: Between January 18 and February 24, 2021, 225 kidney transplant recipients (KTRs) and 45 patients on hemodialysis (HDPs) received two injections of mRNA BNT162b2 vaccine. The postvaccinal humoral and cellular response was explored in the first 45 KTRs and ten HDPs. RESULTS: After the second dose, eight HDPs (88.9%) and eight KTRs (17.8%) developed antispike SARS-CoV-2 antibodies (P<0.001). Median titers of antibodies in responders were 1052 AU/ml (IQR, 515-2689) in HDPs and 671 AU/ml (IQR, 172-1523) in KTRs (P=0.40). Nine HDPs (100%) and 26 KTRs (57.8%) showed a specific T cell response (P=0.06) after the second injection. In responders, median numbers of spike-reactive T cells were 305 SFCs per 106 CD3+ T cells (IQR, 95-947) in HDPs and 212 SFCs per 106 CD3+ T cells (IQR, 61-330) in KTRs (P=0.40). In KTRs, the immune response to BNT162b2 seemed influenced by the immunosuppressive regimen, particularly tacrolimus or belatacept. CONCLUSION: Immunization with BNT162b2 seems more efficient in HDPs, indicating that vaccination should be highly recommended in these patients awaiting a transplant. However, the current vaccinal strategy for KTRs may not provide effective protection against COVID-19 and will likely need to be improved.
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent infection. METHODS: Between January 18 and February 24, 2021, 225 kidney transplant recipients (KTRs) and 45 patients on hemodialysis (HDPs) received two injections of mRNA BNT162b2 vaccine. The postvaccinal humoral and cellular response was explored in the first 45 KTRs and ten HDPs. RESULTS: After the second dose, eight HDPs (88.9%) and eight KTRs (17.8%) developed antispike SARS-CoV-2 antibodies (P<0.001). Median titers of antibodies in responders were 1052 AU/ml (IQR, 515-2689) in HDPs and 671 AU/ml (IQR, 172-1523) in KTRs (P=0.40). Nine HDPs (100%) and 26 KTRs (57.8%) showed a specific T cell response (P=0.06) after the second injection. In responders, median numbers of spike-reactive T cells were 305 SFCs per 106 CD3+ T cells (IQR, 95-947) in HDPs and 212 SFCs per 106 CD3+ T cells (IQR, 61-330) in KTRs (P=0.40). In KTRs, the immune response to BNT162b2 seemed influenced by the immunosuppressive regimen, particularly tacrolimus or belatacept. CONCLUSION: Immunization with BNT162b2 seems more efficient in HDPs, indicating that vaccination should be highly recommended in these patients awaiting a transplant. However, the current vaccinal strategy for KTRs may not provide effective protection against COVID-19 and will likely need to be improved.
Authors: P Pérez-Romero; A Bulnes-Ramos; J Torre-Cisneros; J Gavaldá; T A Aydillo; A Moreno; M Montejo; M C Fariñas; J Carratalá; P Muñoz; M Blanes; J Fortún; A Suárez-Benjumea; F López-Medrano; J L Barranco; M Peghin; C Roca; R Lara; E Cordero Journal: Clin Microbiol Infect Date: 2015-07-29 Impact factor: 8.067
Authors: Brian J Boyarsky; William A Werbel; Robin K Avery; Aaron A R Tobian; Allan B Massie; Dorry L Segev; Jacqueline M Garonzik-Wang Journal: JAMA Date: 2021-05-04 Impact factor: 56.272
Authors: Madhusudhanan Narasimhan; Lenin Mahimainathan; Ellen Araj; Andrew E Clark; John Markantonis; Allen Green; Jing Xu; Jeffrey A SoRelle; Charles Alexis; Kimberly Fankhauser; Hiren Parikh; Kathleen Wilkinson; Annika Reczek; Noa Kopplin; Sruthi Yekkaluri; Jyoti Balani; Abey Thomas; Amit G Singal; Ravi Sarode; Alagarraju Muthukumar Journal: J Clin Microbiol Date: 2021-06-18 Impact factor: 5.948
Authors: Louise Benning; Christian Morath; Marie Bartenschlager; Christian Nusshag; Florian Kälble; Mirabel Buylaert; Matthias Schaier; Jörg Beimler; Katrin Klein; Julia Grenz; Paula Reichel; Asa Hidmark; Gerald Ponath; Maximilian Töllner; Marvin Reineke; Susanne Rieger; Burkhard Tönshoff; Paul Schnitzler; Martin Zeier; Caner Süsal; Ralf Bartenschlager; Claudius Speer Journal: Clin J Am Soc Nephrol Date: 2021-12-22 Impact factor: 8.237
Authors: Ilona Cieślak; Magdalena Kwapisz; Olga Tronina; Joanna Gotlib; Wojciech Lisik; Dariusz Wasiak; Marta Hreńczuk; Mansur Rahnama; Piotr Małkowski Journal: Ann Transplant Date: 2022-09-16 Impact factor: 1.479
Authors: Alexander Lammert; Peter Schnuelle; Holger F Rabenau; Sandra Ciesek; Bernhard K Krämer; Uwe Göttmann; Felix Drüschler; Christine Keller; Daniela Rose; Carsten Blume; Michael Thomas; Niko Kohmer; Anne Lammert Journal: Transplant Direct Date: 2022-10-14
Authors: Jens Van Praet; Marijke Reynders; Dirk De Bacquer; Liesbeth Viaene; Melanie K Schoutteten; Rogier Caluwé; Peter Doubel; Line Heylen; Annelies V De Bel; Bruno Van Vlem; Deborah Steensels; An S De Vriese Journal: J Am Soc Nephrol Date: 2021-09-29 Impact factor: 10.121